Complete Filing Data
K&F GROWTH ACQUISITION CORP. II reported Stockholders Equity of -$9.42 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean K&F GROWTH ACQUISITION CORP. II did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 |
|---|---|
| Net Income Loss | $10.2M |
| Operating Income Loss | -$742.3K |
| General And Administrative Expense | $742.3K |
| Payment Of General And Administrative Costs Through Promissory Note | $48.0K |
| Nonoperating Income Expense | $10.9M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 |
|---|---|---|---|---|
| Net Income Loss | $3.0M | $2.9M | $1.6M | -$45.2K |
| Operating Income Loss | -$178.0K | -$177.3K | -$190.6K | -$45.2K |
| General And Administrative Expense | $178.0K | $177.3K | $190.6K | $45.2K |
| Payment Of General And Administrative Costs Through Promissory Note | $48.0K | $31.2K | ||
| Nonoperating Income Expense | $3.2M | $3.1M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 |
|---|---|---|
| Stockholders Equity | -$9.4M | -$38.2K |
| Retained Earnings Accumulated Deficit | -$9.4M | -$63.2K |
| Liabilities Current | $83.3K | $242.8K |
| Liabilities And Stockholders Equity | $300.6M | $204.6K |
| Liabilities | $10.1M | $242.8K |
| Assets Current | $727.2K | $4.7K |
| Assets | $300.6M | $204.6K |
| Accrued Offering Costs | $75.0K | $7.3K |
| Accrued Liabilities Current | $8.3K | $18.0K |
| Temporary Equity Accretion To Redemption Value | $31.5M | |
| Offering Costs Included In Accrued Offering Costs | $81.8K | |
| Deferred Underwriting Fee | $10.1M | |
| Temporary Equity Carrying Amount Attributable To Parent | $299.9M | |
| Deferred Underwriting Fee Payable | $10.1M | |
| Deferred Offering Costs Paid Through Promissory Note Related Party | ||
| Deferred Costs | $199.9K | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | $577.4K | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $577.4K | |
| Assets Held In Trust Noncurrent | $299.9M | |
| Repayments Of Related Party Debt | ||
| Notes Payable Current | ||
| Deferred Offering Costs Paid Through IPO Promissory Note | $550.00 | |
| Cash | ||
| Repayments Of Notes Payable | $266.1K | |
| Other Liabilities Current | ||
| Deferred Offering Costs Paid By Sponsor In Exchange For Issuance Of Shares | ||
| Cash And Cash Equivalents At Carrying Value |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|
| Stockholders Equity | -$9.2M | -$9.0M | -$8.9M | -$20.2K | |
| Retained Earnings Accumulated Deficit | -$9.2M | -$9.0M | -$8.9M | ||
| Liabilities Current | $78.3K | $84.5K | $102.6K | ||
| Liabilities And Stockholders Equity | $297.9M | $294.9M | $292.0M | ||
| Liabilities | $10.1M | $10.1M | $10.2M | ||
| Assets Current | $918.6K | $1.1M | $1.3M | ||
| Assets | $297.9M | $294.9M | $292.0M | ||
| Accrued Offering Costs | $75.0K | $75.0K | $75.0K | ||
| Accrued Liabilities Current | $3.3K | $9.5K | $27.6K | ||
| Temporary Equity Accretion To Redemption Value | $3.2M | $3.1M | $22.3M | ||
| Offering Costs Included In Accrued Offering Costs | $81.8K | $37.5K | |||
| Deferred Underwriting Fee | $10.1M | $10.1M | $10.1M | ||
| Temporary Equity Carrying Amount Attributable To Parent | $297.0M | $293.8M | $290.7M | ||
| Deferred Underwriting Fee Payable | $10.1M | ||||
| Deferred Offering Costs Paid Through Promissory Note Related Party | $550.00 | $89.3K | |||
| Deferred Costs | |||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | $1.0M | ||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $711.4K | $836.2K | $1.0M | ||
| Assets Held In Trust Noncurrent | $297.0M | $293.8M | $290.7M | ||
| Repayments Of Related Party Debt | $266.1K | ||||
| Notes Payable Current | $217.5K | ||||
| Deferred Offering Costs Paid Through IPO Promissory Note | |||||
| Cash | $711.4K | ||||
| Repayments Of Notes Payable | |||||
| Other Liabilities Current | $217.5K | ||||
| Deferred Offering Costs Paid By Sponsor In Exchange For Issuance Of Shares | 6.7K | ||||
| Cash And Cash Equivalents At Carrying Value | $711.4K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 |
|---|---|
| Increase Decrease In Accrued Liabilities | -$9.8K |
| Proceeds From Issuance Of Private Placement | $9.2M |
| Proceeds From Issuance Initial Public Offering | $281.8M |
| Payments To Acquire Investments | $288.9M |
| Payments Of Stock Issuance Costs | $347.2K |
| Net Cash Provided By Used In Operating Activities | -$849.1K |
| Net Cash Provided By Used In Investing Activities | -$288.9M |
| Net Cash Provided By Used In Financing Activities | $290.4M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $145.1K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q3 2024 |
|---|---|---|
| Increase Decrease In Accrued Liabilities | $9.6K | $5.0K |
| Proceeds From Issuance Of Private Placement | $9.2M | |
| Proceeds From Issuance Initial Public Offering | $281.8M | |
| Payments To Acquire Investments | $288.9M | |
| Payments Of Stock Issuance Costs | $347.2K | |
| Net Cash Provided By Used In Operating Activities | -$392.0K | |
| Net Cash Provided By Used In Investing Activities | -$288.9M | |
| Net Cash Provided By Used In Financing Activities | $290.4M | |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $259.0K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 |
|---|---|---|
| Preferred Stock Shares Authorized | 5.0M | 5.0M |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 |
| Sale Of Stock Number Of Shares Issued In Transaction | 922.7K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|
| Preferred Stock Shares Authorized | 5.0M | 5.0M | 5.0M |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 |
| Sale Of Stock Number Of Shares Issued In Transaction | 922.7K |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 |
|---|---|---|
| Prepaid Expense Current | $149.7K | $4.7K |
| Investment Income Interest | $10.9M | |
| Stock Issued During Period Value New Issues | ||
| Adjustments To Additional Paid In Capital Stock Issued Issuance Costs | $181.6K | |
| Adjustments To Additional Paid In Capital Mark To Market | $2.8M | |
| Additional Paid In Capital | $24.0K | |
| Stock Issued During Period Value Other | $9.2M | |
| Prepaid Expenses Paid In Exchange For Issuance Of Stock | ||
| Payment Of Formation Costs Through Promissory Note |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 |
|---|---|---|---|---|
| Prepaid Expense Current | $207.2K | $266.6K | $263.7K | |
| Investment Income Interest | $3.2M | $3.1M | $1.8M | |
| Stock Issued During Period Value New Issues | $9.2M | $25.0K | ||
| Adjustments To Additional Paid In Capital Stock Issued Issuance Costs | $181.6K | |||
| Adjustments To Additional Paid In Capital Mark To Market | $2.8M | |||
| Additional Paid In Capital | ||||
| Stock Issued During Period Value Other | $9.2M | |||
| Prepaid Expenses Paid In Exchange For Issuance Of Stock | $9.4K | |||
| Payment Of Formation Costs Through Promissory Note | $9.0K |
Most recent annual filing with the SEC: March 27, 2026
Data sourced from SEC EDGAR public filings as of August 7, 2026.